Surgical Digestive Endoscopy, Policlinico Gemelli, Università Cattolica, Rome, Italy.
Gastroenterology and Digestive Endoscopy, Ospedale San Giuseppe, Albano L., Rome, Italy.
Gastrointest Endosc. 2016 Apr;83(4):765-73. doi: 10.1016/j.gie.2015.08.044. Epub 2015 Sep 3.
Flexible endoscopy septotomy for Zenker's diverticulum (ZD) is an alternative to endostapling; however, long-term data are sparse and studies are heterogeneous. The aim of this study was to assess the clinical success of flexible endoscopy diverticuloscope-assisted septotomy according to all ZD-related symptoms and to identify potential prognostic variables.
A prospective database of all patients with ZD undergoing septotomy and followed up for 24 months or longer was analyzed. Septotomy was conducted by using a diverticuloscope-assisted technique. Dysphagia, regurgitation, and respiratory symptoms (during the day and at night) were scored by their weekly frequency from 0 to 3 when on a solid food diet. Clinical success (asymptomatic state) was defined as a maximum of 2 symptoms with a score of 1 (once per week). Prognostic variables of clinical success included age, sex, pretreatment total symptom score, pre- and posttreatment ZD size, and septotomy length. The Kaplan-Meier method and Cox proportional hazards model were used to calculate the crude and adjusted hazard ratio (HR).
Septotomy was attempted and achieved in a single session in 89 patients. Clinical success at the intention-to-treat analysis was 69%, 64%, and 46% at 6, 24, and 48 months, respectively. Adverse events occurred in 3 patients: perforation in 2 (2%) and postprocedural bleeding in 1 (1%). Independent variables for failure at 6 months were a septotomy length ≤25 mm (HR 6.34) and pretreatment ZD size ≥50 mm (HR 11.08), whereas at 48 months, they were septotomy length ≤25 (HR 2.20) and posttreatment ZD size ≥10 mm (HR 2.03). Success rates for ZD ranging in size from 30 mm to 49 mm with a septotomy >25 mm were 100% and 71% at 6 months and 48 months, respectively.
Flexible endoscopic septotomy for ZD is feasible and safe. Treatment success correlates with the length of the septotomy and the size of ZD, which should ultimately determine the appropriate approach.
Zenker 憩室(ZD)的可屈性内镜隔室切开术是内镜缝合器的替代方法;然而,长期数据稀少,研究结果也存在异质性。本研究旨在根据所有与 ZD 相关的症状评估可屈性内镜辅助憩室切开术的临床成功率,并确定潜在的预后变量。
对所有接受隔室切开术并随访 24 个月或更长时间的 ZD 患者的前瞻性数据库进行了分析。隔室切开术采用可屈性内镜辅助技术进行。在固体食物饮食时,通过每周频率(0-3 分)对吞咽困难、反流和呼吸症状(白天和夜间)进行评分。临床成功(无症状状态)定义为最多有 2 个症状且评分 1 分(每周 1 次)。临床成功的预后变量包括年龄、性别、治疗前总症状评分、治疗前后 ZD 大小和隔室切开术长度。采用 Kaplan-Meier 法和 Cox 比例风险模型计算粗风险比(HR)和调整 HR。
89 例患者尝试并成功完成了单一切开术。意向治疗分析的临床成功率分别为 6 个月时 69%、24 个月时 64%和 48 个月时 46%。3 例患者出现不良事件:2 例(2%)穿孔和 1 例(1%)术后出血。6 个月时失败的独立变量为隔室切开术长度≤25mm(HR 6.34)和治疗前 ZD 大小≥50mm(HR 11.08),而 48 个月时的独立变量为隔室切开术长度≤25mm(HR 2.20)和治疗后 ZD 大小≥10mm(HR 2.03)。ZD 大小在 30mm 至 49mm 之间且隔室切开术长度>25mm 的成功率分别为 6 个月时 100%和 48 个月时 71%。
ZD 的可屈性内镜隔室切开术是可行且安全的。治疗成功率与隔室切开术的长度和 ZD 的大小相关,这最终决定了合适的治疗方法。